Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Blood eosinophil counts offer insight into airway inflammation and help identify eosinophilic asthma subtypes that often respond best to inhaled corticosteroids or targeted biologics using thresholds of <150, 150–300, and >300 cells/µL. Clinicians also monitor trends over time to predict treatment response and adjust management.
Several factors can influence counts—from allergies and medications to infections and seasonal changes—and there are important details to consider, so see below for complete information that could impact your next steps in care.
Asthma is a complex respiratory condition characterized by airway inflammation and variable airflow obstruction. Among the cells involved in asthma's inflammatory process, eosinophils play a key role. Measuring blood eosinophil counts helps doctors classify asthma types, predict treatment response, and monitor disease control over time. This guide reviews what blood eosinophil counts mean, the typical reference ranges, and how this information applies to asthma management.
Eosinophils are a type of white blood cell involved in the body's immune response, especially against parasites and in allergic inflammation. In asthma, eosinophils accumulate in the airways, releasing inflammatory mediators that can:
By checking the number of eosinophils circulating in the blood, clinicians get an indirect measure of airway inflammation.
Reference ranges can vary slightly among laboratories, but generally:
Normal blood eosinophil count:
Mild eosinophilia:
Moderate eosinophilia:
Severe eosinophilia:
In asthma care, the most frequently used thresholds are:
300 cells/µL
These cutoffs help identify eosinophilic asthma—a subtype that often responds well to certain anti-inflammatory treatments.
Disease Phenotyping
Treatment Decisions
Monitoring Control
Several factors can influence eosinophil levels, including:
• Allergic triggers (pollen, dust mites, pet dander)
• Parasitic infections
• Certain medications (e.g., beta-blockers, antibiotics)
• Recent corticosteroid use (may temporarily lower counts)
• Seasonal variations (counts may rise in allergy season)
• Underlying conditions (autoimmune diseases, some cancers)
Always inform your healthcare provider about recent infections, medications, or allergies before interpreting your blood eosinophil count.
Sample collection
Laboratory analysis
Reporting
Your doctor will review the results alongside symptom reports, lung function tests, and other lab data.
When you receive your blood eosinophil count:
Compare it to the lab's normal reference range (often printed on the report).
Consider your asthma control level:
Discuss trends over time:
If your eosinophil count falls into the high range (> 300 cells/µL) and you have frequent asthma symptoms, your doctor might:
If counts are low but symptoms persist, your doctor may:
Keeping track of symptoms, peak flow readings, and medication use is essential. If you notice changes in control—wheezing, chest tightness, nighttime awakenings—getting a preliminary assessment of your symptoms can help you understand whether you need urgent care. Try using a Medically approved LLM Symptom Checker Chat Bot to evaluate your respiratory symptoms and receive guidance on next steps before your doctor's appointment.
Always seek immediate help or call emergency services if you experience:
For non-emergency concerns—such as rising eosinophil counts or increasing symptoms—schedule a timely visit with your asthma specialist or primary care doctor.
Understanding your blood eosinophil count reference range provides valuable insight into your asthma subtype and guides treatment decisions. Typical cutoffs (< 150, 150–300, > 300 cells/µL) help identify eosinophilic inflammation and predict responsiveness to corticosteroids or biologic therapies. Always interpret eosinophil levels in the context of symptoms, lung function, and other factors. Regular monitoring, trigger management, and open communication with your healthcare provider are key to achieving optimal asthma control.
If you have concerns about your eosinophil count, asthma control, or potential treatment options, speak to your doctor. Never ignore symptoms that could signal a serious or life-threatening condition—professional medical advice is essential.
(References)
* Nair P, Wenzel S. Eosinophilic asthma: A distinct phenotype and target for therapy. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):947-955. doi: 10.1016/j.jaip.2017.03.003. Epub 2017 Apr 10. PMID: 28408337.
* Casale M, De Candia N, De Siena M, Di Giorgio A, Aliberti S, Confalonieri M. Blood eosinophils as a biomarker in asthma: From diagnosis to treatment. Pulmonology. 2021 Mar-Apr;27(2):161-170. doi: 10.1016/j.pulmoe.2020.10.007. Epub 2020 Nov 23. PMID: 33243577.
* Busse WW, Virchow JC. Management of severe eosinophilic asthma: a review. Allergy. 2021 Jan;76(1):15-28. doi: 10.1111/all.14502. Epub 2020 Sep 28. PMID: 32897455.
* Tran TN, Khatry DB, Ke X, Ward CK, Gossage D. Blood Eosinophil Count and Exacerbation Risk in Patients With Asthma: A Systematic Review and Meta-analysis. J Asthma. 2019 Jan;56(1):21-32. doi: 10.1080/02770903.2018.1439226. Epub 2018 Feb 21. PMID: 29469601.
* Rosenberg HF, Foster PS, Blaikie MJ, Humbles AA. Eosinophils in Asthma: Old Cells, New Tricks. J Allergy Clin Immunol. 2021 May;147(5):1619-1628. doi: 10.1016/j.jaci.2021.03.013. Epub 2021 Mar 22. PMID: 33766750.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.